USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!
Olaparib Tablets

BRIEFING

Olaparib Tablets. Because there is no existing USP monograph for this drug substance, a new monograph based on validated methods of analysis is being proposed.

  1. The liquid chromatographic procedure used in the Assay and the test for Organic Impurities was validated using the Sunfire C18 brand of column with L1 packing. The typical retention time for olaparib is about 17 min.

  2. The liquid chromatographic procedure used in the Dissolution test was validated using the Symmetry C18 brand of column with L1 packing. The typical retention time for olaparib is about 3 min.

 This proposal has undergone the prospective harmonization process with European Pharmacopoeia.

 (SM3: R. Fales)

 Case ID—SUB-1456

USP REFERENCE STANDARDS FOR PURCHASE

USP Olaparib RS
USP Olaparib Related Compound D RS
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!